Escalating interdictions of oil tankers linked to Venezuelan President Nicolás Maduro occur as part of a sweeping naval ...
The case examined GST applicability on large-scale plantation and post-plantation maintenance work by a non-profit entity.
The Act was introduced to tackle project delays, lack of transparency, and misuse of funds, granting homebuyers strong statutory remedies against errant ...
BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...
According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if ...
Were you caught up in either of the two AT&T data breaches from 2019 or 2024? If so, you might be eligible for part of a $177 ...
Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator® platform to ...
PRISM BioLab, Co. Ltd. ("PRISM") and Talus Bioscience, Inc. ("Talus Bio") announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and ...
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its ...
The deadline to file a claim for money from the $177 million AT&T class action settlement is coming up. AT&T agreed to the settlement to resolve a lawsuit that accused it of failing to protect ...
Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback